However, under conditions when apoE derived from macrophages did not reduce hyperlipidemia, the expression of apoE in these cells reduced at least early atherogenesis [7,8], consistent with the idea that macrophage-derived apoE has anti-atherogenic functions that are independent of the plasma clearance of apoB-containing lipoproteins. The gene discussed is APOE; the disease is hyperlipidemia.